hotspot -WSS

hotspot

author：focus 2025-10-01 11:46:37 - browse：617

A pharmacy technician prepares prescriptions for packaging and shipping after being filled. health policy coverage from STAT — George Frey/Getty Images

WASHINGTON — Republicans and Democrats alike want to stop drug shortages from happening. The vexing question is how.

The White House and a whole host of government agencies oversee programs aimed at mitigating drug shortages, including the Food and Drug Administration, the Administration for Strategic Preparedness and Response, the White House Office of Science and Technology Policy, the Department of Defense, and the Department of Commerce.

The White House also has a new task force that is supposed to put together recommendations for fighting drug shortages, one it formed early this year in response to news of the worsening drug shortage crisis as the country began running out of an increasing number of chemotherapies. It has met with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm solutions, but it’s not clear what it has in mind or when it will make those recommendations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： A public scorecard can help hold safety

WSS

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Anthos stroke drug appears safer than common blood thinner

In early work, researchers turn to CRISPR to treat Alzheimer's

NYU radiologists take on the challenge of expensive MRI machines

CRISPR pioneers react to Casgevy, first gene

focus

hotspot

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

Startup Neumora takes a novel depression drug to Phase 3

What does generative AI mean for health care? We asked experts

Childhood cancer progress stalls for Black, Hispanic kids: Report

The high cost of giving birth even with insurance

Childhood cancer progress stalls for Black, Hispanic kids: Report

23andMe had bad news about my health. I wish a person had delivered it

Does good food count as health care? Study aims to find out

How to save PrEP access — and even expand it

At Orexo, a ‘turning point’ for everything but digital health

explore

Gain of function research would be limited under House proposal

David Sabatini, ex

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Cosmetics set for new safety regulation. Why the industry is on board

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Startup Neumora takes a novel depression drug to Phase 3

hotspot

hotspot

Wikipedia

knowledge